EUCTR2019-003299-38-SE进行中（未招募）1 期
A randomized double blind, multicenter trial to assess time-interval between cytoreductive surgery and adjuvant chemotherapy after administration of local anesthetic intraperitoneally/perioperatively in advanced epithelial ovarian cancer - IPLA-OVCA
Karolinska University Hospital0 个研究点目标入组 220 人开始时间: 2019年10月18日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women > 18 years
- •ASA I-III
- •Scheduled for upfront cytoreductive surgery for stage III or IV epithelial ovarian cancer
- •Signed written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 110
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 110
排除标准
- •Contraindication to epidural anesthesia
- •Allergy to any component drugs used during epidural or intraperitoneal anesthesia (Ropivacaine, Sufentanil)
- •Uncontrolled renal, liver, heart failure or ischemic heart disease
- •Speech, language or cognitive difficulties
- •Women in whom cytoreductive surgery is not attempted at time of upfront laparotomy due to extent of disease
研究者
相似试验
进行中（未招募）
1 期
A randomized double blind, multicenter trial to assess time-interval between cytoreductive surgery and adjuvant chemotherapy after administration of local anesthetic intraperitoneally/perioperatively in advanced epithelial ovarian cancer - IPLA-OVCAAdvanced epithelial ovarian cancer stage III-IVMedDRA version: 20.0Level: PTClassification code: 10033128Term: Ovarian cancer Class: 100000004864CTIS2023-507732-20-00Karolinska University Hospital220
尚未招募
2 期
BeatNF2 trialJPRN-jRCT2080224914Kiyoshi Saito60
进行中（未招募）
1 期
A study to investigate the safety and efficacy of a six month oral treatment with a twice daily dose of BAY 1142524 in comparison to placebo in patients with reduced left-ventricular ejection fraction after acute myocardial infarction.EUCTR2016-002167-33-CZBayer AG185
进行中（未招募）
1 期
A study to investigate the safety and efficacy of a six month oral treatment with a twice daily dose of BAY 1142524 in comparison to placebo in patients with reduced left-ventricular ejection fraction after acute myocardial infarctioeft-ventricular dysfunction after acute myocardial infarctionEUCTR2016-002167-33-ESBayer AG140
进行中（未招募）
1 期
A study to investigate the safety and efficacy of a six month oral treatment with a twice daily dose of BAY 1142524 in comparison to placebo in patients with reduced left-ventricular ejection fraction after acute myocardial infarctioEUCTR2016-002167-33-DEBayer AG185